Wake Forest Baptist Comprehensive Cancer Center
Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, United States26 results ยท Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC | Locally Advanced Pancreatic Cancer | Active, not recruiting | Phase 3 | 2026-09-30 | NCT03257033 | |
| A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, endocrine system disorder, gastric cancer, gastric neoplasm, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, stomach disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-09-29 | NCT04396821 | |
| Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma | pancreatic adenocarcinoma | Recruiting | Phase 2 | 2026-09-28 | NCT05825066 | |
| Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2026-09-25 | NCT04253964 | |
| Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2026-09-22 | NCT05696782 | |
| Postoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC Greater Than 6 Weeks After Surgery | Head and Neck Neoplasms, Neoplasms by Site, head and neck cancer, neoplasm | Recruiting | Not applicable | 2026-09-17 | NCT06607406 | |
| Improving Exercise Capacity With a Tailored Physical Activity Intervention | Hemic and Lymphatic Diseases, Hodgkins lymphoma, Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, non-Hodgkin lymphoma, skin disorder | Active, not recruiting | Not applicable | 2026-09-09 | NCT05595577 | |
| MRI in High-Grade Glioma Patients Undergoing Chemoradiation | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, epithelial neoplasm, glioma, malignant glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Not applicable | 2026-08-17 | NCT05212272 | |
| Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative Study | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not stated | 2026-08-10 | NCT06567704 | |
| Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity | Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm | Active, not recruiting | Not stated | 2026-08-06 | NCT03890614 | |
| Cardiac Outcomes With Near-Complete Estrogen Deprivation | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Active, not recruiting | Not applicable | 2026-08-05 | NCT05309655 | |
| A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy | Embolism and Thrombosis, Genital Diseases, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Thromboembolism, Urogenital Diseases, Urogenital Neoplasms, cardiovascular disorder, endocrine system disorder, gonadal disorder, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, neoplasm, testicular cancer, testicular disorder, vascular disorder, venous thromboembolism | Recruiting | Phase 2 | 2026-07-24 | NCT06866964 | |
| Patient Descriptors Of Cancer-Related Fatigue: A Mixed Methods Pilot Study Of Cancer Survivors | Fatigue, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cancer, neoplasm | Recruiting | Not stated | 2026-07-24 | NCT06634381 | |
| Toxicity Genetic Determinants and Response to Azacitidine and Venetoclax in AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Not stated | 2026-07-24 | NCT06580106 | |
| REmotely-delivered Supportive Programs for Improving Surgical Pain and disTrEss | Neurologic Manifestations, Pain, Parasomnias, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Pain, Signs and Symptoms, anxiety, anxiety disorder, female reproductive organ cancer, nervous system disorder, psychiatric disorder, sleep disorder, sleep-wake disorder | Active, not recruiting | Phase 3 | 2026-07-24 | NCT05625360 | |
| Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance | Brain Metastases, Neoplasms by Site, Thoracic Neoplasms, brain disorder, bronchial neoplasm, bronchogenic carcinoma, central nervous system cancer, central nervous system disorder, lung disorder, lung neoplasm, neoplasm, nervous system disorder, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2026-07-17 | NCT05692635 | |
| Cetuximab After Immunotherapy for the Treatment of Head and Neck Squamous Cell Cancer | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma | Recruiting | Phase 2 | 2026-07-17 | NCT04375384 | |
| The Better, Harder, Faster, Stronger Study | Adnexal Diseases, Cognition Disorders, Cognitive Dysfunction, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Frailty, Genital Diseases, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, cognitive disorder, endocrine system disorder, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, psychiatric disorder, uterine disorder | Recruiting | Not stated | 2026-07-15 | NCT07220512 | |
| Evaluation of the Pathobiology of CALR-mutated MPN Cells | Embolism and Thrombosis, Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, cardiovascular disorder, hematologic disorder, myeloproliferative neoplasm, thrombotic disease, vascular disorder | Recruiting | Not stated | 2026-07-13 | NCT06480591 | |
| Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer | Neoplasms by Site, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Not stated | 2026-07-13 | NCT04174742 | |
| Optimizing Health Related Quality of Life Measurement in Adolescent and Young Adult Oncology | Hematopoietic Neoplasms, Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm | Recruiting | Not stated | 2026-06-30 | NCT06897137 | |
| I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer | Disease Attributes, Disease Progression, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Pathologic Complete Response, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, angiosarcoma, breast cancer, breast disorder, breast neoplasm, neoplasm, sarcoma, skin disorder, triple-negative breast carcinoma, vascular cancer | Recruiting | Phase 2 | 2026-05-06 | NCT01042379 | |
| Telehealth Intervention for Improving Distress and Financial Toxicity in the Caregivers | Hematopoietic and Lymphatic System Neoplasm; Malignant Solid Neoplasm | Recruiting | Not applicable | 2026-04-13 | NCT06709404 | |
| Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Prostatic Cancer, Castration-Resistant, Prostatic Neoplasms, Castration-Resistant, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder, refractory malignant neoplasm | Recruiting | Phase 2 | 2026-04-13 | NCT04337580 | |
| I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Respiration Disorders, adult acute respiratory distress syndrome, disease, lung disorder, pneumonia, respiratory failure, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Phase 2 | 2026-03-16 | NCT04488081 |